| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8cf79e1891b8fe2095d282bf9f57612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68f2bd3d611c7a2a832128d8430d9193
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d8dc1fd2742ff4485c6d5e00b359169
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae32abd99c869304e08f3771fc23e965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ae7d7e218acf1144f8ac05e12e44cad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c58f6b055c123a42d3082c31ce80d50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498 |
| filingDate |
2011-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2bf2d39a008a889238187b7c8623c3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b20dd48de4ec576c39b0f5323dc8ac68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_745c3aae87de57a50a87b5d22ae9a1cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6d0a51143382565111624df9a39fd3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68161323933f71a7891f570daf3c7bdf |
| publicationDate |
2013-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013059857-A1 |
| titleOfInvention |
Methods and compositions for safe and effective treatment of telangiectasia |
| abstract |
Improved methods and compositions for safe and effective treatment of telangiectasia or a symptom associated with telangiectasia in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of brimonidine and a pharmaceutically acceptable carrier. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9861632-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8513247-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9861631-B2 |
| priorityDate |
2010-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |